InsidersTradesSigma
인바디 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 인바디 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 인바디 has published 19 insider filings. The latest transaction was filed on 26 June 2026 (Other). Among the most active insiders: 차인준. Every trade is free.
19
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 26 June 2026
Declarations19 total
151,806 sharesKRXDART:20260604000561
19 of 19 declarations
About 인바디
InBody is a company specializing in the development of body composition technology and health solutions. It is listed on the XKRX market.